SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-346888
Filing Date
2021-12-03
Accepted
2021-12-02 17:50:01
Documents
12
Period of Report
2021-12-02
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d487825d8k.htm   iXBRL 8-K 22435
  Complete submission text file 0001193125-21-346888.txt   143448

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA lyel-20211202.xsd EX-101.SCH 2870
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE lyel-20211202_lab.xml EX-101.LAB 18122
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lyel-20211202_pre.xml EX-101.PRE 11390
5 EXTRACTED XBRL INSTANCE DOCUMENT d487825d8k_htm.xml XML 3358
Mailing Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Filer) CIK: 0001806952 (see all company filings)

IRS No.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40502 | Film No.: 211467989
SIC: 2834 Pharmaceutical Preparations